Temporally, during the acute phase of stroke, γδ T cells rapidly release IL-17A following stroke onset to amplify early detrimental immune responses (164), while Th17 cells function throughout the stroke process, including in pathogenesis, induction of secondary injury, and regulation of late-stage repair (165, 166). Here, IL17A is linked to stroke disorder.